Hiremii Group Limited Completes $1.8 million Placement with Strategic Investors.
Hiremii Group Limited (ASX: HMI) released a price-sensitive announcement confirming firm commitments to raise $1.76 million before costs through a placement to strategic professional and sophisticated investors. The company will issue 42.0 million fully paid ordinary shares at $0.042 per share, with investors also receiving one option for every share subscribed, subject to shareholder approval. The issue price represents a premium to both the 15-day VWAP and the last closing price, indicating support from incoming investors. The proceeds are earmarked to support the commercial rollout of Hiremii, expand AI-led optimisation initiatives, and pursue growth opportunities across the Asia Pacific, Australia, and the Americas. The placement strengthens Hiremii’s balance sheet and introduces investors with strong regional networks that may support future business development. Shares will settle in late January 2026.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to this. Read our Privacy Policy and Terms & Conditions
Hiremii Group Limited Completes $1.8 million Placement with Strategic Investors.
Hiremii Group Limited (ASX: HMI) released a price-sensitive announcement confirming firm commitments to raise $1.76 million before costs through a placement to strategic professional and sophisticated investors. The company will issue 42.0 million fully paid ordinary shares at $0.042 per share, with investors also receiving one option for every share subscribed, subject to shareholder approval. The issue price represents a premium to both the 15-day VWAP and the last closing price, indicating support from incoming investors. The proceeds are earmarked to support the commercial rollout of Hiremii, expand AI-led optimisation initiatives, and pursue growth opportunities across the Asia Pacific, Australia, and the Americas. The placement strengthens Hiremii’s balance sheet and introduces investors with strong regional networks that may support future business development. Shares will settle in late January 2026.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au